| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8324506 | The International Journal of Biochemistry & Cell Biology | 2012 | 9 Pages |
Abstract
Doxorubicin (Dox) significantly reduces bone marrow stem cells (BMSCs) while increasing breast cancer stem cells (BCSCs) in tumor-bearing mice; those effects are correlated with the levels of glucosylceramide synthase (GCS), that enzyme regulates ceramide glycosylation and the synthesis of glycosphingolipids (GSLs).
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Biochemistry
Authors
Kaustubh N. Bhinge, Vineet Gupta, Salman B. Hosain, Seetharama D. Satyanarayanajois, Sharon A. Meyer, Benny Blaylock, Qian-Jin Zhang, Yong-Yu Liu,